Overview
Clomid is classified as a PCT (post-cycle therapy) and ancillary compound. Racemic mixture of enclomiphene (trans) and zuclomiphene (cis) isomers.
With a half-life of ~7 days (168 hours), Clomid supports less frequent dosing schedules. Taken orally, it has a bioavailability of approximately 95% via its primary route.
Half-life approximately 7 days. Zuclomiphene has estrogenic receptor activity. One-compartment model.
Mechanism of Action
Clomid's pharmacological activity involves the following key pathways:
Selective Estrogen Receptor Modulation
Clomid acts as a selective estrogen receptor modulator, functioning as an antagonist in breast tissue while having varying effects in other estrogen-sensitive tissues.
Hypothalamic Feedback
By blocking estrogen receptors in the hypothalamus, Clomid interrupts negative feedback, which can stimulate endogenous gonadotropin production.
Dosing Protocols
The following protocols represent commonly observed dosing patterns. These are observational summaries, not recommendations.
Dose
10 mg/day
Route
Oral
Frequency
Once weekly
Duration
4-8 weeks
Dose
50 mg/day
Route
Oral
Frequency
Once weekly
Duration
4-8 weeks
Frequently Asked Questions
What is Clomiphene (Clomid) and how does it work?
Clomiphene citrate (Clomid) is a selective estrogen receptor modulator (SERM) that stimulates the hypothalamic-pituitary-gonadal axis to increase testosterone production. It contains two geometric isomers: enclomiphene (trans-isomer, ~62%), which is anti-estrogenic and drives the desired PCT effects, and zuclomiphene (cis-isomer, ~38%), which has estrogenic activity. By blocking estrogen receptors in the hypothalamus, clomiphene increases GnRH release, which stimulates LH and FSH secretion from the pituitary, signaling the testes to produce testosterone.
What is the half-life of Clomid and why does it matter?
The pharmacokinetics of clomiphene are complicated by its two isomers having vastly different half-lives. Enclomiphene (the anti-estrogenic isomer) has a relatively short half-life of approximately 5–10 hours, while zuclomiphene (the estrogenic isomer) has a much longer half-life and can remain detectable in plasma for over a month after discontinuation. This means the desired anti-estrogenic effects clear quickly, but the estrogenic effects of zuclomiphene continue to accumulate with repeated dosing — a key reason enclomiphene as a standalone compound has gained popularity.
What is the standard Clomid PCT dosage protocol?
A commonly observed PCT protocol is 50 mg per day for the first 2 weeks, followed by 25 mg per day for the remaining 2 weeks, totaling 4 weeks. For more suppressive cycles, protocols starting at 100 mg per day for the first week, tapering to 50 mg for 2 weeks, then 25 mg for the final week have been reported. Research has observed that doses as low as 25 mg daily are effective at restoring endogenous testosterone production in many cases, suggesting that higher doses may not always be necessary.
What side effects are reported with Clomid in men?
The most commonly reported side effects include mood swings, irritability, and emotional volatility — attributed largely to the accumulation of the estrogenic zuclomiphene isomer. Visual disturbances (blurred vision, floaters, photophobia) are reported more frequently with clomiphene than with tamoxifen, though they are usually reversible upon discontinuation. In clinical comparisons, adverse effects were reported in 47% of clomiphene users versus 13.8% of enclomiphene users. Decreased libido was observed in 33% of clomiphene users compared to 8.6% with enclomiphene.
Why has Enclomiphene become more popular than Clomid?
The zuclomiphene isomer in Clomid is estrogenic and accumulates due to its long half-life (detectable for weeks after stopping), which contributes to mood changes, decreased libido, and reduced energy — the opposite of what PCT is intended to achieve. Enclomiphene isolates only the anti-estrogenic trans-isomer, providing the LH/FSH stimulation without the estrogenic accumulation. Clinical data has shown that enclomiphene produces comparable testosterone elevation with statistically significantly fewer side effects, including zero reported mood changes versus 9.1% with clomiphene.
Can Clomid be used as a long-term TRT alternative?
Clomiphene has been used off-label for male hypogonadism as an alternative to testosterone replacement therapy, with the advantage of preserving fertility by maintaining LH/FSH production rather than suppressing it. However, the accumulation of zuclomiphene with long-term use raises concerns about estrogenic side effects over extended periods. For this reason, enclomiphene (the isolated anti-estrogenic isomer) is increasingly observed as the preferred SERM for long-term testosterone support, as it avoids zuclomiphene accumulation while maintaining comparable efficacy.